Aptahem’s CSO to present at Biologics World Nordics Conference
Aptahem’s CSO Dr Luiza Jedlina has been invited to speak at the Biologics World Nordics conference in Copenhagen on 7 March 2024.The title of the presentation is ”A Novel RNA Aptamer Targets Exosite 2 on Thrombin, Offering a Potential Treatment for Systemic Inflammation through a Unique Mechanism”. More about the conference is found via this link . For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@aptahem.com About Aptahem Aptahem AB (APTA) is a clinical stage biotechnology company